SAN DIEGO, May 20, 2020 /PRNewswire/ — Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary non-viral gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the first patient has been dosed in its Phase 1 clinical trial evaluating P-PSMA-101, its autologous CAR-T therapeutic…

Read More

Our Mission: To invest in Kentucky start-up technology companies who have identified a clear exit strategy, the ability to create strong financial returns for our members, and a promise to create new jobs for the Kentucky economy. Visit https://bit.ly/3dAVW3p to learn more about becoming a member of Bluegrass Angels. #angelinvesting #startuplex #Kentucky #businessinvestment #technology

Read More